Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Alpha-Gal specific humoral immune response to bioprostheses. Edition No. 1

VDM Publishing House, Sep 2010, Pages: 84


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

It has been shown that alpha-Gal is a relevant xenoantigen present on bioprostheses and elicits a specific IgM immune response. The aim of this work was to investigate whether that immune response proceeds after valve implantation. Plasma samples were collected from patients who underwent biovalve implantation or mechanical valve replacement, prior to, at ten days and at three months after cardiac surgery. ELISA was performed to quantify Gal specific antibodies. Three bioprosthetic tissue samples were obtained from patients who had to undergo reoperation within one week or one year after the initial operation. Presence of Gal epitopes and cell nuclei was determined. Alpha-Gal specific IgG was significantly increased three months after implantation of bioprostheses. In explanted bioprostheses one year after implantation, no Gal epitopes could be detected. These results indicate that the implantation of bioprostheses elicits a specific immune response against Gal bearing cells. The complete absence of Gal positive structures 12 months after implantation indicates a specific degradation of Gal bearing cells through previous exposure to the human blood circuit.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds